6505--Fluticasone/Salmeterol Inh Powder

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0009 for an unrestricted procurement for Fluticasone/Salmeterol Inhaler, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name and strength of the drug being supplied as it will appear on the label. Offerors shall also provide a unique 11-digit NDC number for all items offered; the NDC number must be specific to the offering company and to the drug being supplied. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All inhalers must be individually boxed and must contain the bar code. (e.g., inhalers etc.) All bottles must be compatible with automated dispensing units (Baxter ATC Canisters, Optifill, etc. Glass bottles are not acceptable for the product type offered. Items are identified in the Schedule of Supplies and in Attachment C. By submitting an offer in response to this solicitation, the offeror certifies that all offered products have passed any required stability testing for all proposed package sizes Solicitation # 36E79726R0009 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 23, 2026, with a tentative closing date of March 9, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to [email protected]. The estimated annual requirements are as follows: Line Item 1: FLUTICASONE 100MCG/SALMETEROL 50MCG INHL,ORAL POWDER 60 (Doses), 30 Day Supply Total EST Annual Usage (BT): 317,019 Canister Line Item 2: FLUTICASONE 250MCG/SALMETEROL 50MCG INHL,ORAL,POWDER 60 (Doses), 30 Day Supply Total EST Annual Usage (BT): 1,479,360 Canister Line Item 3: FLUTICASONE 500MCG/SALMETEROL 50MCG INHL,ORAL,POWDER 60 (Doses), 30 Day Supply Total EST Annual Usage (BT): 504,192 Canister